CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)
$38.9 -1.35 (-3.354%)
Analysed CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) News Sources
Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer
15-04-2026
yahoo.com
Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026
08-04-2026
yahoo.com
Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More
28-03-2026
fool.com
Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly
26-03-2026
yahoo.com
Is Crinetics Pharmaceuticals (CRNX) Pricing Reflect Its Sharp Swings And DCF Upside Potential
14-03-2026
yahoo.com
This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough
13-03-2026
fool.com
Battery Storage Stock Up 50% in a Year Draws New $110M Investment. Here's What You Should Know
13-03-2026
fool.com
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings
13-03-2026
fool.com
Crinetics Pharmaceuticals Highlights Early PALSONIFY Sales, EU Milestone, and GPCR Pipeline at TD Cowen Conf.
09-03-2026
marketbeat.com
Crinetics Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary
27-02-2026
moby.co
What is the current price of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)?
The current price of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) is $38.9.
CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) since the previous trading day is $-1.35.
CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) since the previous trading day is -3.354%.
What is the most recent average sentiment score for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)?
The most recent average sentiment score for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)?
The most recent sentiment for CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ) is .
SEC-8K** Filing Available For CRINETICS PHARMACEUTICALS IN (CRNX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.